SCYX
SCYNEXIS Inc
Price:  
0.72 
USD
Volume:  
53,888.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SCYX EV/EBITDA

-1029.3%
Upside

As of 2025-07-03, the EV/EBITDA ratio of SCYNEXIS Inc (SCYX) is -0.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SCYX's latest enterprise value is 21.16 mil USD. SCYX's TTM EBITDA according to its financial statements is -28.82 mil USD. Dividing these 2 quantities gives us the above SCYX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 7.1x - 8.1x 7.6x
Forward P/E multiples 8.2x - 14.4x 11.0x
Fair Price (5.91) - (5.82) (6.69)
Upside -920.6% - -908.3% -1029.3%
0.72 USD
Stock Price
(6.69) USD
Fair Price

SCYX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-02 -0.73
2025-07-01 -0.71
2025-06-30 -0.67
2025-06-27 -0.69
2025-06-26 -0.76
2025-06-25 -0.77
2025-06-24 -0.76
2025-06-23 -0.75
2025-06-20 -0.75
2025-06-18 -0.77
2025-06-17 -0.77
2025-06-16 -0.82
2025-06-13 -0.85
2025-06-12 -0.87
2025-06-11 -0.96
2025-06-10 -0.95
2025-06-09 -0.92
2025-06-06 -1.00
2025-06-05 -0.96
2025-06-04 -1.03
2025-06-03 -0.96
2025-06-02 -0.96
2025-05-30 -0.94
2025-05-29 -0.97
2025-05-28 -1.02
2025-05-27 -0.75
2025-05-23 -0.81
2025-05-22 -0.80
2025-05-21 -0.80
2025-05-20 -0.84
2025-05-19 -0.89
2025-05-16 -0.83
2025-05-15 -1.08
2025-05-14 -1.05
2025-05-13 -1.07
2025-05-12 -1.07
2025-05-09 -1.03
2025-05-08 -1.06
2025-05-07 -1.06
2025-05-06 -1.03
2025-05-05 -1.07
2025-05-02 -1.15
2025-05-01 -1.09
2025-04-30 -1.10
2025-04-29 -1.10
2025-04-28 -1.08
2025-04-25 -1.14
2025-04-24 -1.20
2025-04-23 -1.07
2025-04-22 -1.04